Effect of synbiotic supplementation in treatment of diabetic hemodialysis patients
Phase 3
- Conditions
- Hemodialysis.Chronic kidney disease
- Registration Number
- IRCT2017090133941N17
- Lead Sponsor
- Vice chancellor for research, Kashan University of Medical Sciences
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete
- Sex
- All
- Target Recruitment
- 60
Inclusion Criteria
Diabetic hemodialysis patients
Aged 18 to 80 years
Exclusion Criteria
Taking probiotic and/or synbiotic supplements, antioxidant and/or anti-inflammatory supplements within 3 months prior to the enrollment
Required changes in medications during the study and recent diabetes diagnosis
Study & Design
- Study Type
- interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Insulin resistance. Timepoint: At the beginning of the study and after 12 weeks of intervention. Method of measurement: Calculation using HOMA formula.
- Secondary Outcome Measures
Name Time Method